PUBLISHER: The Business Research Company | PRODUCT CODE: 1942492
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942492
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
Tariffs are impacting the breast imaging devices market by increasing costs of imported imaging sensors, semiconductors, X-ray tubes, magnets, and precision electronic components used in mammography, MRI, and ultrasound systems. Hospitals and diagnostic imaging centers in North America and Europe are most affected due to reliance on imported high-end imaging equipment, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising capital equipment prices and delaying procurement cycles for healthcare providers. However, they are also encouraging localized assembly, regional supplier development, and increased investment in domestic medical imaging manufacturing capabilities.
The breast imaging devices market research report is one of a series of new reports from The Business Research Company that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The breast imaging devices market size has grown strongly in recent years. It will grow from $5.27 billion in 2025 to $5.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising breast cancer screening awareness, expansion of diagnostic imaging centers, increasing availability of digital mammography systems, growing healthcare expenditure, adoption of advanced ultrasound technologies.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing investments in ai-enabled diagnostic tools, rising demand for early cancer detection solutions, expansion of outpatient imaging services, growing focus on personalized breast care, technological advancements in non-ionizing imaging systems. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising use of 3D and digital breast tomosynthesis, growing integration of multimodal imaging platforms, expansion of minimally invasive diagnostic imaging, enhanced focus on early-stage cancer detection.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market are Siemens Healthineers AG, Hologic Inc, GE Healthcare, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V, Aurora Imaging Technology Inc, Delphinus Medical Technologies Inc, Micrima Limited, SonoCine Inc, Planmed Oy, Carestream Health Inc, Dilon Technologies Inc, Toshiba Medical Systems Corporation, SuperSonic Imagine SA, IMS Giotto (Giotto Imaging), Samsung Medison Co Ltd, Hitachi Ltd, Koning Corporation, Metaltronica S.p.A, CMT Medical Technologies Ltd, Gamma Medica Inc, KUB Technologies Inc
North America was the largest region in the breast imaging devices market in 2025. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Breast Imaging Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses breast imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for breast imaging devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast imaging devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.